Junichi Sakamoto Selected Research

Cisplatin (Platino)

11/2023	Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
11/2022	Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease.
1/2020	Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.
1/2019	A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.
1/2018	A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
1/2018	A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).
1/2016	Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
5/2015	Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
4/2015	A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
1/2014	Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junichi Sakamoto Research Topics

Disease

86	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2002
64	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 09/2003
54	Neoplasms (Cancer) 01/2024 - 09/2003
19	Colonic Neoplasms (Colon Cancer) 08/2023 - 10/2004
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2020 - 12/2012
13	Neoplasm Metastasis (Metastasis) 02/2021 - 08/2006
11	Neutropenia 12/2020 - 01/2004
11	Diarrhea 05/2018 - 01/2004
11	Breast Neoplasms (Breast Cancer) 09/2014 - 02/2004
10	Carcinoma (Carcinomatosis) 02/2022 - 05/2003
10	Ascites 01/2020 - 05/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2001
6	Disease Progression 01/2018 - 07/2007
5	Body Weight (Weight, Body) 10/2018 - 11/2004
5	Adenocarcinoma 01/2018 - 07/2007
5	Fatigue 01/2018 - 01/2004
5	Stomatitis 01/2018 - 01/2004
4	Rectal Neoplasms (Rectal Cancer) 10/2023 - 01/2018
4	Lymphatic Metastasis 10/2020 - 07/2009
4	Anemia 01/2018 - 11/2008
4	Hypersensitivity (Allergy) 09/2016 - 03/2013
3	Pain (Aches) 10/2021 - 06/2009
3	Lung Neoplasms (Lung Cancer) 05/2021 - 04/2017
3	Wilms Tumor (Wilm's Tumor) 02/2019 - 05/2008
3	Anorexia 01/2018 - 01/2004
3	Obesity 01/2017 - 06/2014
3	Glioblastoma (Glioblastoma Multiforme) 09/2016 - 05/2008
3	Leukopenia 08/2012 - 01/2004
2	Fibrosis (Cirrhosis) 03/2024 - 01/2003
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 11/2004
2	Ileus 01/2020 - 08/2015
2	Multiple Myeloma 10/2019 - 12/2007
2	Infections 04/2018 - 08/2010
2	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 01/2004
2	Proteinuria 12/2016 - 12/2003
2	Sarcoma (Soft Tissue Sarcoma) 12/2016 - 10/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2016 - 10/2013
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2016 - 04/2013

Drug/Important Bio-Agent (IBA)

36	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2003
30	Capecitabine (Xeloda)FDA Link 11/2023 - 02/2004
26	Fluorouracil (Carac)FDA LinkGeneric 06/2023 - 11/2003
23	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 03/2004
22	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2023 - 12/2011
20	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 06/2004
15	Dasatinib (BMS 354825)FDA Link 03/2020 - 01/2014
14	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2011
14	Cetuximab (Erbitux)FDA Link 06/2022 - 04/2014
13	Leucovorin (Folinic Acid)FDA Link 06/2023 - 12/2011
11	Peptides (Polypeptides)IBA 02/2019 - 06/2007
8	TegafurIBA 02/2022 - 04/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
8	XELOXIBA 01/2017 - 01/2011
7	UracilIBA 02/2022 - 07/2014
6	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 10/2010
5	S-1 plus cisplatinIBA 11/2023 - 04/2010
5	Panitumumab (Vectibix)FDA Link 12/2022 - 01/2017
5	pyrimidineIBA 01/2022 - 09/2003
5	Tyrosine Kinase InhibitorsIBA 03/2020 - 10/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019 - 02/2004
5	Protein Subunit VaccinesIBA 01/2018 - 04/2006
4	VaccinesIBA 02/2019 - 05/2008
4	PicibanilIBA 04/2016 - 05/2001
3	Immunoglobulin G (IgG)IBA 03/2024 - 08/2010
3	Carcinoembryonic AntigenIBA 01/2022 - 01/2003
3	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2004
3	gosha-jinki-ganIBA 10/2021 - 12/2009
3	Messenger RNA (mRNA)IBA 07/2020 - 06/2007
3	Carboplatin (JM8)FDA LinkGeneric 11/2019 - 04/2017
3	ErbB Receptors (EGF Receptor)IBA 11/2019 - 09/2011
3	HLA-A*24:02 antigenIBA 02/2019 - 02/2014
3	hange-shashintoIBA 01/2018 - 05/2014
3	polysaccharide-KIBA 01/2018 - 04/2006
3	Trastuzumab (Herceptin)FDA Link 01/2017 - 09/2011
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2014
3	Monoclonal AntibodiesIBA 01/2017 - 11/2006
3	Alanine Transaminase (SGPT)IBA 12/2016 - 11/2008
3	AntigensIBA 11/2006 - 01/2003
2	CytokinesIBA 01/2020 - 08/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 12/2015
2	Drinking WaterIBA 05/2018 - 06/2010
2	CreatinineIBA 01/2018 - 12/2003
2	Phosphotransferases (Kinase)IBA 10/2017 - 01/2014
2	taxaneIBA 01/2017 - 04/2013
2	thiamine triphosphorate (TTP)IBA 07/2016 - 08/2006
2	LentinanIBA 01/2016 - 07/2009

Therapy/Procedure

62	Drug Therapy (Chemotherapy) 07/2023 - 01/2002
59	Therapeutics 10/2022 - 09/2003
42	Adjuvant Chemotherapy 07/2023 - 01/2004
14	Gastrectomy 02/2021 - 01/2004
12	Neoadjuvant Therapy 07/2020 - 01/2003
7	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 01/2004
6	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 11/2003
5	Drug Tapering 07/2023 - 02/2006
5	Immunotherapy 01/2018 - 12/2007
4	Colectomy 10/2023 - 07/2015
4	TP protocol 01/2014 - 04/2007
3	Oral Administration 05/2021 - 01/2015
3	Pancreaticoduodenectomy 01/2020 - 04/2013
3	Kampo Medicine (Kampo) 07/2015 - 04/2013
2	Esophagectomy 01/2024 - 01/2004